Acetaminophen
Phase 2Recruiting 0 views this week 0 watching⚡ Active
Interest: 42/100
42
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post Operative Analgesia
Conditions
Post Operative Analgesia, Bariatric Surgery, Bariatric Surgery (Gastric Bypass), Bariatric Surgery Patients, Perioperative Analgesia
Trial Timeline
Nov 13, 2024 → May 1, 2026
NCT ID
NCT06658574About Acetaminophen
Acetaminophen is a phase 2 stage product being developed by Johnson & Johnson for Post Operative Analgesia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06658574. Target conditions include Post Operative Analgesia, Bariatric Surgery, Bariatric Surgery (Gastric Bypass).
What happened to similar drugs?
20 of 20 similar drugs in Post Operative Analgesia were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00261560 | Approved | Completed |
| NCT06658574 | Phase 2 | Recruiting |
| NCT02911961 | Approved | Withdrawn |
Competing Products
20 competing products in Post Operative Analgesia